Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $140.51 million as of July 1, 2025. Its market cap has decreased by -15.00% in one year.

• Market Cap: 140.51M
• Enterprise Value: 241.50M
• 1-Year Change: -15.00%
• Ranking: #3926
• Category: Micro-Cap
• Stock Price: $2.22

Market Cap Chart

Since September 9, 2002, Galectin Therapeutics's market cap has increased from $31.60M to $140.51M, an increase of 344.64%. That is a compound annual growth rate of 6.76%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2025	140.50M	73.46%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	72.69%
Dec 31, 2002	52.00M	64.56%

View and export this data all the way back to 2002. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	696.15B
Johnson & Johnson	366.71B
AbbVie	322.03B
Novo Nordisk	304.96B
UnitedHealth Group	280.41B
Novartis AG	235.85B
Abbott Laboratories	233.80B
AstraZeneca	217.42B